Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/12750699

Download in:

View as

General Info

PMID
12750699